Theoretical performance of non-invasive prenatal testing for chromosome imbalances using counting of cell-free DNA fragments in maternal plasma
Authors:
- 27 March 2014
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 34 (8) , 778-783
Abstract
Objective The aim of this study was to calculate the theoretical performance of non‐invasive prenatal testing based on counting methods. Methods The calculations were based on Gaussian distributions of the percent cell‐free DNA from selected chromosome regions in affected and normal pregnancies. The means were derived from the relative genomic size of the chromosome region and the fetal fraction. The standard deviations were derived from the bivariate distributions of proportional counts. Depth of sequencing was varied from 50 000 000 to 100 000 and fetal fraction from 20% to 3%. Detection rate was estimated for a fixed 0.13% false‐positive rate. Results When either depth or fetal fraction is high, expected Down syndrome screening detection rates are high. However, when fetal fraction is low, deeper sequencing is required to obtain high detection rates. For microdeletion and microduplication screening, deeper sequencing is routinely required to consistently achieve high detection rates. There are small differences in the ability to detect a microdeletion compared with a duplication of the same size. Conclusion While the theoretical calculations do not necessarily reflect the performance of currently available non‐invasive prenatal testing tests, it confirms that fetal fraction is a key factor. Efficacy can be substantially altered depending on the abnormality under investigation and the depth of sequencing. © 2014 John Wiley & Sons, Ltd.Keywords
This publication has 23 references indexed in Scilit:
- Integration of Noninvasive DNA Testing for Aneuploidy into Prenatal Care: What Has Happened Since the Rubber Met the Road?Clinical Chemistry, 2014
- Non‐invasive prenatal testing for aneuploidy: current status and future prospectsUltrasound in Obstetrics & Gynecology, 2013
- Genome-Wide Fetal Aneuploidy Detection by Maternal Plasma DNA SequencingObstetrics & Gynecology, 2012
- Digital PCR for Noninvasive Detection of Aneuploidy: Power Analysis Equations for FeasibilityFetal Diagnosis and Therapy, 2012
- Selective analysis of cell‐free DNA in maternal blood for evaluation of fetal trisomyPrenatal Diagnosis, 2012
- DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation studyGenetics in Medicine, 2011
- Optimal Detection of Fetal Chromosomal Abnormalities by Massively Parallel DNA Sequencing of Cell-Free Fetal DNA from Maternal BloodClinical Chemistry, 2011
- Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical settingAmerican Journal of Obstetrics and Gynecology, 2011
- Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasmaProceedings of the National Academy of Sciences, 2008
- Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal bloodProceedings of the National Academy of Sciences of the United States of America, 2008